Dr Devesh J Dhasmana
Clinical Senior Lecturer
Research areas
Consultant Respiratory Medicine, NHS Fife
Senior Clinical Lecturer
Selected publications
-
Cohort profile: SARS-CoV-2 Immunity and Reinfection EvaluatioN (SIREN)
Foulkes, S., Munro, K., Khawam, J., Russell, S., Dunne, A., Wilson, K., Corrigan, D., de Lacy, E., Brown, C. S., Otter, A., Charlett, A., SIREN Study Group, Atti, A., Islam, J., Hopkins, S. & Hall, V., Apr 2026, In: International Journal of Epidemiology. 55, 2, p. 1-9 9 p., dyag032.Research output: Contribution to journal › Article › peer-review
-
Open access
Deep-learning algorithm diagnostic support for usual interstitial pneumonia pattern recognition in fibrotic interstitial lung disease
Fermoyle, C. C., Mackintosh, J. A., Navaratnam, V., Ellis, S. J., Cooper, W. A., Goh, N. S. L., Moodley, Y., Reynolds, P. N., Zappala, C. J., Hopkins, P., Glaspole, I. N., Corte, T. J., Walsh, S. L. F. & SOFIA Project Consortium, 1 Apr 2026, (E-pub ahead of print) In: Respirology. Early View, p. 1-10 10 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Jan 2026, In: Lancet Infectious Diseases. 26, 1, p. 34-45 12 p.Research output: Contribution to journal › Article › peer-review
-
Open access
The crucial role of normative ageing in respiratory pathogenesis
International Consortium to Classify Ageing-Related Pathologies (ICCARP) respiratory working group members, Weight, C. M., Tatler, A. L., Huckstepp, R. T. R., Adcock, I. M., Barnes, P. J., van Beek, E. J. R., Christopher, G., Clifford, R. L., Dhasmana, D. J., Hart, S. P., Hashmat, A., Noble, S., Sayers, I., Short, E., Stinson, R., Calimport, S. R. G. & Bentley, B. L., Apr 2026, In: The Lancet Healthy Longevity. 7, 4, p. 1-13 13 p., 100842.Research output: Contribution to journal › Review article › peer-review
-
Open access
A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration
Nguyen, B. T., Bertrand, J., Agyeman, A. A., Zhang, S., Yu, L.-M., Harris, V., Little, P., Butler, C. C., Breuer, J., Lowe, D. M., Standing, J. F., Guedj, J. & PANORAMIC study group , 15 Jun 2025, In: Journal of Infectious Diseases. 231, 6, p. e1080–e1090 11 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Defining an ageing-related pathology, disease or syndrome: international consensus statement
Short, E., Calimport, S., Bentley, B. & ICCARP, Apr 2025, In: GeroScience. Online first, 8 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Healthcare worker views on antimicrobial resistance in chronic respiratory disease
Ananth, S., Adeoti, A. O., Ray, A., Middleton, P. G., Ekkelenkamp, M., Thee, S., Shah, A. & AMR-Lung Clinical Research Collaboration, 22 Jan 2025, In: Antimicrobial Resistance & Infection Control. 14, p. 1-12 12 p., 1.Research output: Contribution to journal › Article › peer-review
-
Open access
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Harris, V., Holmes, J., Gbinigie-Thompson, O., Rahman, N. M., Richards, D. B., Hayward, G., Dorward, J., Lowe, D. M., Standing, J. F., Breuer, J., Khoo, S., Petrou, S., Hood, K., Ahmed, H., Carson-Stevens, A., Nguyen-Van-Tam, J. S., Patel, M. G., Saville, B. R., Francis, N. & Thomas, N. P. B. & 22 others, , 1 Jan 2025, In: The Lancet Infectious Diseases. 25, 1, p. 68-79 12 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Mar 2025, In: EClinicalMedicine. 81, p. 1-10 10 p., 103080.Research output: Contribution to journal › Article › peer-review
-
Open access
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Sept 2025, In: Lancet Infectious Diseases. 25, 9, p. 1000-1010 11 p.Research output: Contribution to journal › Article › peer-review